EF
EW icon

Empowered Funds’s Edwards Lifesciences EW Stock Holding History

Empowered Funds’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.9M Sell
43,120
-38,899
-47% -$3.26M 0.02% 819
2026
Q1 		$6.57M Buy
+82,019
New +$6.76M 0.04% 535
2025
Q4 		– Sell
-16,764
Closed -$1.3M – 1277
2025
Q3 		$1.3M Sell
16,764
-21,208
-56% -$1.66M 0.01% 1093
2025
Q2 		$2.97M Buy
37,972
+26,596
+234% +$1.98M 0.03% 641
2025
Q1 		$825K Sell
11,376
-14,157
-55% -$1.01M 0.01% 1061
2024
Q4 		$1.89M Buy
25,533
+1,501
+6% +$105K 0.03% 757
2024
Q3 		$1.59M Buy
24,032
+2,324
+11% +$169K 0.02% 751
2024
Q2 		$2.01M Buy
21,708
+1,585
+8% +$140K 0.03% 610
2024
Q1 		$1.92M Buy
20,123
+12,112
+151% +$1.02M 0.03% 639
2023
Q4 		$611K Buy
8,011
+2,813
+54% +$196K 0.02% 945
2023
Q3 		$360K Buy
5,198
+963
+23% +$77.4K 0.01% 1017
2023
Q2 		$399K Buy
4,235
+1,570
+59% +$136K 0.01% 886
2023
Q1 		$220K Buy
+2,665
New +$209K 0.01% 490

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Empowered Funds's EW Position: Q2 2026 in Review

Empowered Funds reduced its Edwards Lifesciences (EW) stake by 47% in Q2 2026, selling an estimated $3.26M and leaving 43,120 shares worth $3.9M. The position accounts for 0.02% of the portfolio, ranked #819.

Empowered Funds first reported a position in EW in Q1 2023 and has held it in 13 quarters since. The position peaked at $6.57M in Q1 2026. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Empowered Funds held 43,120 shares of Edwards Lifesciences worth $3.9M as of Q2 2026.
  • Empowered Funds sold 38,899 Edwards Lifesciences shares in Q2 2026, an estimated $3.26M.
  • Edwards Lifesciences made up 0.02% of Empowered Funds's portfolio in Q2 2026, its #819 holding.
  • Empowered Funds first reported a position in Edwards Lifesciences in Q1 2023 and has held it in 13 quarters since.
  • Empowered Funds's Edwards Lifesciences position peaked at $6.57M in Q1 2026.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.